Document is current
Any future updates will be listed below
-
Authors
Brown, Jacqueline http://orcid.org/0000-0002-1130-6414
Scardo, Savannah
Method, Michael
Schlauch, Dan
Misch, Amanda
Picard, Shaita
Hamilton, Erika
Jones, Suzanne
Burris, Howard
Spigel, David
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 20 July 2021
Accepted: 17 April 2022
First Online: 6 May 2022
Declarations
:
: The study was approved by the Institutional Review board of Sarah Cannon, the Cancer Institute of HCA Healthcare (Sarah Cannon Outcomes Master Retrospective Protocol [MR01]). Research was performed in accordance with the Declaration of Helsinki. Informed consent was not required because the patient data were de-identified before receipt.
: Not applicable.
: JB and MM are full-time employees of Eli Lilly and Company and Eli Lilly and Company shareholders. SS is a full-time employee of Eli Lilly and Company. DS [1], AM, SP, EH, SJ, HB, and DS [2] are employees of Sarah Cannon Research Institute.
